122 results
Page 5 of 7
424B3
vzsmnj c9fcu4e
15 Feb 19
Prospectus supplement
12:00am
S-4/A
EX-10.28
zm6pv7
25 Jan 19
Registration of securities issued in business combination transactions (amended)
5:12pm
S-4/A
EX-10.27
qtn9r
25 Jan 19
Registration of securities issued in business combination transactions (amended)
5:12pm
S-4/A
EX-10.25
hay w9iu165f4nx
25 Jan 19
Registration of securities issued in business combination transactions (amended)
5:12pm
S-4/A
EX-10.24
18uuihvo
25 Jan 19
Registration of securities issued in business combination transactions (amended)
5:12pm
S-4/A
EX-5.1
ohc9bip
25 Jan 19
Registration of securities issued in business combination transactions (amended)
5:12pm
S-4/A
EX-10.29
0uknn mi3l
25 Jan 19
Registration of securities issued in business combination transactions (amended)
5:12pm
S-4/A
r2dmxo 6n8g
25 Jan 19
Registration of securities issued in business combination transactions (amended)
5:12pm
S-4/A
EX-10.26
5o6 r1r7ca4h
25 Jan 19
Registration of securities issued in business combination transactions (amended)
5:12pm
S-4
EX-10.19
71cwaw22n
20 Dec 18
Registration of securities issued in business combination transactions
9:56pm
S-4
EX-10.23
2lkept7h62yu4j w1
20 Dec 18
Registration of securities issued in business combination transactions
9:56pm
S-4
EX-10.20
qk228ns4cdzolg as
20 Dec 18
Registration of securities issued in business combination transactions
9:56pm
S-4
aamwroqjbmwqeuj
20 Dec 18
Registration of securities issued in business combination transactions
9:56pm
S-4
EX-10.22
b6xkf1
20 Dec 18
Registration of securities issued in business combination transactions
9:56pm
S-4
EX-10.21
3e2s rbg9vdazg
20 Dec 18
Registration of securities issued in business combination transactions
9:56pm
8-K
EX-2.3
c8esmf
26 Nov 18
Edge Therapeutics Enters into Merger Agreement with PDS Biotechnology to Form Clinical-Stage Cancer Immunotherapy Company
6:58am
8-K
nyzqg
26 Nov 18
Edge Therapeutics Enters into Merger Agreement with PDS Biotechnology to Form Clinical-Stage Cancer Immunotherapy Company
6:58am
8-K
EX-2.1
rnyw3c t6f0kkx
26 Nov 18
Edge Therapeutics Enters into Merger Agreement with PDS Biotechnology to Form Clinical-Stage Cancer Immunotherapy Company
6:58am
8-K
EX-2.2
vq8 q1zydo1y
26 Nov 18
Edge Therapeutics Enters into Merger Agreement with PDS Biotechnology to Form Clinical-Stage Cancer Immunotherapy Company
6:58am